FrancophonIA/ELRC3.0 huggingface dataset:
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Fexeric's benefits are greater than its risks and recommended that it be approved for use in the EU.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Fexeric večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: This prevents the phosphate from being absorbed into the body and helps to keep down the phosphate levels in the blood.
Slovenian: To preprečuje absorpcijo fosfatov v telesu in pomaga vzdrževati nizke ravni fosfatov v krvi.
English: Patients should keep to their prescribed low
Slovenian: Bolniki se morajo držati predpisane diete z
English: In addition, the company that markets Fexeric will carry out a study to gain further information on the long-term safety of Fexeric, particularly in older patients.
Slovenian: Poleg tega bo družba, ki trži zdravilo Fexeric, izvedla študijo, s katero bo pridobila dodatne podatke o njegovi dolgoročni varnosti, predvsem pri starejših bolnikih.
English: Patients with severe kidney disease have difficulty eliminating phosphate from their bodies.
Slovenian: Bolniki s hudo ledvično boleznijo imajo težave z izločanjem fosfatov iz telesa.
English: What benefits of Fexeric have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Fexeric izkazalo v študijah?
English: The overall safety profile was considered acceptable and comparable to other phosphate binders.
Slovenian: Splošni varnostni profil je bil sprejemljiv in primerljiv z
English: Both studies looked at the change in the amount of phosphate in the blood, measured in mg/dl.
Slovenian: V obeh študijah so opazovali spremembo količine fosfatov v krvi, izmerjeno v mg/dl.
English: The most common side effects with Fexeric (which may affect more than 1 in 10 people) are changes in bowel movements (diarrhoea or constipation) and discoloured faeces.
Slovenian: Najpogostejša neželena učinka zdravila Fexeric (ki lahko prizadeneta več kot 1 osebo od 10) sta spremenjeno delovanje črevesja (driska ali zaprtje) in obarvano blato.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Fexeric, including the appropriate precautions to be followed by healthcare
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni
English: It is not intended to provide practical advice on how to use Fexeric.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: In the first study, Fexeric was as effective as sevelamer carbonate, an approved medicine, in lowering phosphate levels in 359 patients with long-term kidney disease: after 12 weeks both treatments resulted in a reduction in phosphate levels of around 2 mg/dl.
Slovenian: V prvi študiji je bilo zdravilo Fexeric enako učinkovito kot sevelamerijev karbonat, ki je že odobreno zdravilo, pri zniževanju ravni fosfatov pri 359 bolnikih z dolgotrajno ledvično boleznijo: po 12 tednih so pri obeh oblikah zdravljenja ugotovili znižanje ravni fosfatov za približno 2 mg/dl.
English: Fexeric must not be used in patients with low blood-phosphate levels, patients who have severe problems with the stomach and gut (such as bleeding from the gut), and those with iron accumulation disorders such as haemochromatosis.
Slovenian: Zdravilo Fexeric se ne sme uporabljati pri bolnikih z nizkimi ravnmi fosfatov v krvi, bolnikih, ki imajo hude težave z želodcem in črevesom (kot je krvavitev iz črevesa) ter bolnikih z motnjami kopičenja železa, kot je hemokromatoza.
English: A build-up of phosphate leads to hyperphosphataemia and in the long-term can cause complications such as heart
Slovenian: Kopičenje fosfatov povzroča hiperfosfatemijo, ki lahko dolgoročno vodi do zapletov, kot so bolezni srca in kosti.
English: For more information about treatment with Fexeric, read the package leaflet (also part of the EPAR) or contact
Slovenian: Za več informacij o zdravljenju z zdravilom Fexeric preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Blood-phosphate levels should be monitored regularly during treatment.
Slovenian: Med zdravljenjem je treba redno spremljati ravni fosfatov v krvi.
English: Fexeric is a medicine used to control hyperphosphataemia (high levels of phosphate in the blood) in adults with long-term kidney disease.
Slovenian: Fexeric je zdravilo, ki se uporablja za nadzorovanje hiperfosfatemije (visokih ravni fosfatov v krvi) pri odraslih z dolgotrajno ledvično boleznijo.
English: The active substance in Fexeric, ferric citrate coordination complex, is a phosphate binder.
Slovenian: Zdravilna učinkovina zdravila Fexeric, koordinacijski kompleks železovega citrata, je vezalec fosfatov.
English: For practical information about using Fexeric, patients should read the package leaflet or contact their
Slovenian: Za praktične informacije o uporabi zdravila Fexeric naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: The CHMP considered that Fexeric is effective at controlling blood-phosphate levels in patients with long-term kidney disease, whether they are on dialysis or not.
Slovenian: Menil je, da je zdravilo Fexeric učinkovito pri uravnavanju ravni fosfatov v krvi pri bolnikih z dolgotrajno ledvično boleznijo, ne glede na to, ali so na dializi ali ne.
English: When taken with meals, the iron contained in Fexeric binds to phosphate from food in the gut, forming a compound that is then eliminated in the stools.
Slovenian: Pri jemanju ob obrokih se železo v zdravilu Fexeric veže na fosfate iz hrane v črevesu in tako ustvari
English: The recommended starting dose is 3 to 6 tablets per day, taken in divided doses together with meals.
Slovenian: Zdravilo Fexeric je na voljo v obliki tablet po 1 g. Priporočeni začetni odmerek je od 3 do 6 tablet na dan, ki se jemljejo v ločenih odmerkih ob obrokih.
English: It contains the active substance ferric citrate coordination
Slovenian: koordinacijski kompleks železovega citrata
English: The study showed that blood-phosphate levels fell on average by 0.7 mg/dl with Fexeric compared with 0.3 mg/dl with placebo.
Slovenian: V njej so pokazali, da so se pri zdravilu Fexeric ravni fosfatov v krvi v povprečju znižale za 0,7 mg/dl,
English: Fexeric was shown to be effective at controlling blood-phosphate levels in 2 main studies in patients with long-term kidney disease and hyperphosphataemia.
Slovenian: V dveh glavnih študijah pri bolnikih z dolgotrajno ledvično boleznijo in hiperfosfatemijo so dokazali, da je zdravilo Fexeric učinkovito pri nadzorovanju ravni fosfatov v krvi.
English: EMA/23705/2010 EMEA/H/C/1102
Slovenian: 20. januar 2009 EMA/139270/2010 EMEA/H/C/1102
English: It was to be available as tablets.
Slovenian: Na voljo naj bi bilo v tabletah.
English: The main measures of effectiveness were based on the amount of time the patients spent awake after they had first fallen asleep and improvements in the quality of sleep over the first four to 12 weeks of treatment.
Slovenian: Glavna merila učinkovitosti so temeljila na dolžini časa budnosti bolnikov od takrat, ko so prvič zaspali, ter na izboljšanju kakovosti spanja v prvih štirih do dvanajstih tednih zdravljenja.
English: The company presented results of four main studies involving over 3,000 adults who had difficulty staying asleep.
Slovenian: Družba je predložila rezultate štirih glavnih študij, v katere je bilo vključenih več kot 3 000 odraslih, ki so se med spanjem pogosto zbujali.
English: The effects of Sliwens were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila Sliwens so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: There was also a lack of information comparing the long-term use of Sliwens with placebo.
Slovenian: Prav tako ni bilo na voljo podatkov o primerjavi dolgotrajne uporabe zdravila Sliwens s placebom.
English: The CHMP considered the effect of Sliwens on sleep to be small.
Slovenian: CHMP je menil, da so učinki zdravila Sliwens na spanec majhni.
English: Sliwens is a medicine that contains the active substance eplivanserin.
Slovenian: Sliwens je zdravilo, ki vsebuje zdravilno učinkovino eplivanserin.
English: The company informed the CHMP that there were no consequences for patients in clinical trials or compassionate use, since all ongoing clinical trials have been discontinued.
Slovenian: Družba je obvestila CHMP, da umik nima nobenih posledic za bolnike, ki trenutno sodelujejo v kliničnih preskušanjih ali programih sočutne uporabe, ker so bila vsa klinična preskušanja v teku prekinjena.
English: The Committee was also concerned about the risk of diverticulitis (inflammation in little sacs or pouches in the intestines) in patients taking the medicine.
Slovenian: Odbor je izrazil tudi zadržke glede tveganja za pojav divertikulitisa (vnetja majhnih vrečk ali žepkov v črevesju) pri bolnikih, ki jemljejo to zdravilo.
English: On 18 December 2009, Sanofi-Aventis officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sliwens, for use in adults with chronic (long-term) insomnia who have difficulty staying asleep.
Slovenian: Družba Sanofi-Aventis je dne 18. decembra 2009 uradno obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za pridobitev dovoljenja za promet z zdravilom Sliwens, namenjenim zdravljenju bolnikov s kronično (dolgotrajno) nespečnostjo, ki se med spanjem pogosto zbujajo.
English: The active substance in Sliwens, eplivanserin, is a 5-hydroxytryptamine receptor antagonist.
Slovenian: Zdravilna učinkovina v zdravilu Sliwens, eplivanserin, je antagonist receptorjev 5-hidroksitriptamina.
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin) EMA/23705/2010
Slovenian: Umik vloge za pridobitev dovoljenja za promet z zdravilom Sliwens (eplivanserin) EMA/139270/2010
English: It blocks receptors in the brain called 5-hydroxytryptamine type 2 receptors, which are involved in regulating the daily cycle of being asleep and being awake.
Slovenian: Zavira receptorje v možganih, imenovane receptorji 5-hidroksitriptamina tipa 2, ki sodelujejo pri uravnavanju dnevnega cikla spanja in budnosti.
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin)
Slovenian: Umik vloge za pridobitev dovoljenja za promet z zdravilom Sliwens (eplivanserin)
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Sliwens could not have been approved.
Slovenian: Na podlagi pregleda podatkov in odgovorov družbe na seznam vprašanj, ki jih zastavil CHMP, je v času umika vloge izrazil določene zadržke in je začasno menil, da zdravila Sliwens ni mogoče odobriti.
English: study involving 283 adults compared Sliwens with lormetazepam (another medicine used to treat insomnia) looked at how sleepy the patients were the morning after taking Sliwens.
Slovenian: V peti študiji, v katero je bilo vključenih 283 odraslih, so zdravilo Sliwens primerjali z lormetazepamom (drugim zdravilom za zdravljenje nespečnosti) in proučevali, kako zaspani so bili bolniki naslednje jutro po zaužitju zdravila Sliwens.
English: Sliwens was expected to be used in adults with long-term insomnia (difficulty sleeping).
Slovenian: Zdravilo Sliwens naj bi se uporabljalo pri odraslih z dolgotrajno nespečnostjo (težavo s spancem).
English: By blocking these receptors, eplivanserin was expected to modify the sleep-wake cycle, helping people with long-term insomnia to stay asleep.
Slovenian: Eplivanserin naj bi z zaviranjem teh receptorjev spremenil ta cikel ter ljudem z dolgotrajno nespečnostjo pomagal zaspati in se med spanjem ne zbujati.
English: The studies compared Sliwens with placebo (a dummy treatment).
Slovenian: V študijah so zdravilo Sliwens primerjali s placebom (zdravilom brez zdravilne učinkovine).
English: What was Sliwens expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Sliwens uporabljalo?
English: It was to be used in patients who have difficulty staying asleep.
Slovenian: Zdravilo naj bi se uporabljalo pri bolnikih, ki se med spanjem pogosto zbujajo.
English: What is Sliwens?
Slovenian: Kaj je zdravilo Sliwens?
English: How was Sliwens expected to work?
Slovenian: Kako naj bi zdravilo Sliwens delovalo?
English: 6th floor, ap 37+Sofia Bulgaria
Slovenian: 6th floor, ap 37+Sofia
English: Budapest H-1138 Hungary
Slovenian: Budapest H-1138
English: Baxter Hungary Kft Népfürdő u. 22.
Slovenian: Madžarska Baxter Hungary Kft Népfürdő u. 22.
English: Zeletavská 1525/1
Slovenian: Želetavská 1525/1
English: B-7860 Lessines Belgium
Slovenian: B-7860 Lessines
English: VIOSER SA, 9th Km National Highway TrikalaLarissis,
Slovenian: 9th Km National Highway TrikalaLarissis,
English: Baxter MédicoFarmacêutica, Lda.
Slovenian: Portugalska Baxter MédicoFarmacêutica, Lda.
English: Box 35, Taxiarhes, Trikala,
Slovenian: P.O. Box 35, Taxiarhes, Trikala,
English: Luxembourg Baxter S.A. Boulevard René Branquart 80
Slovenian: Luksembourg Baxter S.A. Boulevard René Branquart 80
English: BAXTER HELLAS Ltd, Metsovou 3, Neo Irakleion 14121, Athens Greece
Slovenian: BAXTER HELLAS Ltd, Metsovou 3, Neo Irakleion 14121, Athens
English: Hydroksyetyloskro bia 200/0,5 Baxter
Slovenian: Hydroksyetyloskrobi a 200/0,5 Baxter
English: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius, Lithuania
Slovenian: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius,
English: 0.450.55 AV. MW 200K, sodium chloride
Slovenian: 0.45-0.55 AV. MW 200K, natrijev klorid
English: Kruczkowskiego 8 00-380 Warszawa Poland
Slovenian: Kruczkowskiego 8 00-380 Warszawa Poland hidroksietilškrob
English: Baxter S.p.A. Piazzale dell industria,
Slovenian: Piazzale dell industria,
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Slovenian: Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila,
English: IP24 3SE United Kingdom
Slovenian: IP24 3SE
English: Voluven 6% Solution for Infusion (Polyolefine/Freefle x Bag
Slovenian: Voluven 6% Solution for Infusion (Polyolefine/Freeflex Bag
English: Sodium chloride
Slovenian: natrijev klorid
English: Baxter Deutschland GmbH, Edissonstrasse 4+Unterschleissheim,
Slovenian: Edissonstrasse 4+Unterschleissheim,
English: 9th Km National Highway Trikal-Larissa, P.O.
Slovenian: 9th Km National Highway Trikal-Larissa, P.O. Box 35, Taksiarhes Trikalon,
English: Baxter B.V.
Slovenian: Nizozemska Baxter B.V.
English: Caxton Way, Thetford, Norfolk IP24 3SE United Kingdom
Slovenian: Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24 3SE
English: Serumwerk Bernburg AG
Slovenian: Serumwerk Bernburg AG Hallesche Landstr.
English: Fresenius Kabi Pharma Portugal, Lda Av. do Forte, 3
Slovenian: Portugalska Fresenius Kabi Pharma Portugal, Lda
English: PlasmaHES RedibagInfusionsloesung
Slovenian: PlasmaHES Redibag - Infusionsloesung
English: Box 1110 +1120 DE-34209 Melsungen Germany
Slovenian: B. Braun Melsungen AG P.O. Box 1110 +1120 DE-34209 Melsungen Germany
English: 69007 Lyon France hydroxyethyl starch 200
Slovenian: 69007 Lyon France hidroksietilškrob 200 000 PLASMOHES 6%, solution pour perfusion
English: B.Braun Melsungen AG Carl Braun Strasse 1 Melsungen
Slovenian: Madžarska B.Braun Melsungen AG Carl Braun Strasse 1
English: B. Braun Melsungen A.G.
Slovenian: Luksembourg B.Braun Melsungen A.G.
English: Stella-Klein-Loew-Weg
Slovenian: Baxter Healthcare GmbH Stella-Klein-Loew-Weg
English: Belgium B. Braun Melsungen AG Carl-Braun-Strasse 1
Slovenian: Češka republika B. Braun Melsungen AG Carl-Braun Strasse 1
English: Fresenius Kabi AB, 751 74 Uppsala Sweden hydroxyethyl starch,
Slovenian: Fresenius Kabi AB, Rapsgatan 7, SE-751 74 Uppsala, Sweden hidroksietilškrob (HES), natrijev klorid, voda
English: D-34212 Melsungen
Slovenian: D-34212 Melsungen Germany
English: B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany hydroxyethyl starch, Sodium chloride, Potassium chloride, Calcium chloride, Magnesium chloride hexahydrate, sodium acetate, Malic acid
Slovenian: B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany hidroksietilškrob, natrijev klorid, kalijev klorid, kalcijev klorid, magnezijev klorid heksahidrat, natrijev acetat, jabolčna kislina
English: Poli(O-2-hydroxyethyl) starch
Slovenian: poli(O-2-hidroksietil)škrob Volulyte
English: Poly-(o-2-hydroxyethyl)starch (M.W 200000) + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate
Slovenian: Greece poli(O-2-hidroksietil)škrob (M.W 200000) + natrijev acetat trihidrat + natrijev klorid + kalijev klorid + magnezijev klorid heksahidrat
English: Sodium Chlorid, Hydroxyethyl starch
Slovenian: natrijev klorid, hidroksietilškrob
English: Fresenius Kabi Nederland B.V. Molenberglei 7 2627 Schelle Belgium active substance: hydroxyethyl starch (MR
Slovenian: Fresenius Kabi NV Molenberglei 7 2627 Schelle Belgium hidroksietilškrob
English: Sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, hydroxyethyl starch 130/0.42
Slovenian: United Kingdom natrijev klorid, kalijev klorid, kalcijev klorid dihidrat, magnezijev klorid heksahidrat, natrijev acetat trihidrat, hidroksietilškrob 130/0.42
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,42 , Sodium chloride
Slovenian: poli(0-2-hidroksietil)škrob 130 kDa mol.substitucija natrijev klorid
English: United Kingdom poly (o-2hydroxyethyl)starch sodium chloride
Slovenian: United Kingdom poli(o-2-hidroksietil)škrob, natrijev klorid
English: Sodium Chloride, malic acid, Calcium Chloride, Potassium Chloride, Magnesium Chloride, Sodium acetate
Slovenian: natrijev klorid, jabolčna kislina, kalcijev klorid, kalijev klorid, magnezijev klorid, natrijev acetat
English: ul.Hrubieszowska 2 01-209 Warszawa, Poland
Slovenian: ul.Hrubieszowska 2 01-209 Warszawa, Poland poli(O-2hidroksietil)škrob, natrijev klorid
English: Poli(O-2-hydroxyethyl) starch, Sodium chloride
Slovenian: poli(O-2hidroksietil)škrob, natrijev klorid
English: Portugal
Slovenian: Germany
English: Hydroxyethyl Starch + Sodium Acetate Trihydrate + Sodium Chloride + Potasium Chloride + Magnesium Chloride Hexahydrate
Slovenian: hidroksietilškrob + natrijev acetat trihidrat + natrijev klorid + kalijev klorid + magnezijev klorid heksahidrat
English: 60g/l, 6g/l, 0.4g/l, 0.134g/l,
Slovenian: 60g/l, 6g/l, 0.4g/l,
English: Tetraspan 6% 60 g/l, 6,25 g/l, 0,3 g/l, 0,37 g/l,
Slovenian: Tetraspan 6% 60 g/l, 6,25 g/l, 0,3 g/l,
English: Poly-(o-2-hydroxyethyl)starch (MW 200000) + Sodium Chloride + Potassium Chloride + Calcium Chloride Dihydrate +
Slovenian: Greece poli(O-2-hidroksietil)škrob (M.W 200000) + natrijev klorid + kalijev klorid + kalcijev klorid dihidrat + magnezijev klorid heksahidrat + natrijev acetat trihidrat + jabolčna kislina
English: B. Braun Melsungen AG Carl-Braun-Strasse 1 34212 Melsungen Germany hydroxyethyl starch,
Slovenian: B. Braun Melsungen AG Carl-Braun-Strasse 1 34212 Melsugen Germany natrijev klorid, hidroksietilškrob
English: VENOFUNDIN 60.0 g/l, 9 g/l
Slovenian: 60,0 g/, 9,0 g/l
English: Belgium Fresenius Kabi NV Molenberglei 7
Slovenian: Madžarska Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1
English: Tetraspan 10% 100 g/l, 6,25 g/l, 0,3 g/l, 0,37 g/l,
Slovenian: Tetraspan 10% 100 g/l, 6,25 g/l, 0,3 g/l,
English: Poly(0-2hydroxyethyl)starch 200 kDa mol.substitution 0,43-0,55, Sodium chloride
Slovenian: D-34212 Melsungen poli(0-2-hidroksietil)škrob 130 kDa mol.substitucija natrijev klorid
English: Tetraspan 6 % 60g/l, 6,25g/l, 0,30 g/l, 0.37 g/l,
Slovenian: Tetraspan 6 % 60g/l, 6,25g/l, 0,30 g/l, 0.37 g/l, 0,20 g/l,
English: Fresenius Kabi Nederland B.V. Molenberglei 7 2627 Schelle Belgium active substance: hydroxyethyl starch (polymere 130/0.4) and sodium chloride
Slovenian: Fresenius Kabi EOOD 1 "Alexander Jendov" str. 6th floor, ap 37+Sofia 1113 Bulgaria poli(O-2hidroksietil)škrob, natrijev klorid
English: 0.37 g/l, 0.2 g/l, 3.27 g/l, 0.67 g/l
Slovenian: 0,20 g/l, 3.27 g /l, 0.67 g/l
English: Sodium Chloride, Potassium Chloride, Magnesium Chloride, Sodium acetate, hydrochloric acid
Slovenian: natrijev klorid, kalijev klorid, magnezijev klorid, natrijev acetat, klorovodikova kislina
English: Czech Republic hydroxyethyl starch, Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium acetate trihydrate
Slovenian: Czech Republic hidroksietilškrob, natrijev klorid, kalijev klorid, kalcijev klorid dihidrat, magnezijev klorid heksahidrat, natrijev acetat trihidrat
English: Hydroxyethyl Starch + Sodium Chloride + Potasium Chloride + Calcium Chloride Dihydrate + Magnesium Chloride Hexahydrate + Sodium Acetate Trihydrate
Slovenian: Greece hidroksietilškrob + natrijev klorid + kalijev klorid + kalcijev klorid dihidrat + magnezijev klorid heksahidrat + natrijev acetat trihidrat
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,38-0,45 , Sodium acetate trihydrate, sodium chloride, potassium chloride, magnesium chloride hexahydrate
Slovenian: poli(0-2-hidroksietil)škrob 130 kDa mol.substitucija natrijev acetat trihidrat, natrijev klorid, kalijev klorid, magnezijev klorid heksahidrat
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,42 , Sodium chloride, Potassium chloride, Calcium chloride trihydrate, Magnesium chloride hexahydrate, sodium acetate trihydrate
Slovenian: Belgium poli(0-2-hidroksietil)škrob 130 kDa mol.substitucija natrijev klorid kalijev klorid, kalcijev klorid trihidrat, magnezijev klorid heksahidrat, natrijev acetat trihidrat
English: Refortan 10 % 9 g/l, 100 g/l
Slovenian: Refortan 10 % 9 g/l, 100 g/l raztopina za infundiranje
English: S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov, Romania
Slovenian: S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov, Romania hidroksietilškrob, natrijev acetat trihidrat, kalijev klorid, magnezijev klorid heksahidrat, natrijev klorid
English: Volulyte 6% 60 g/l, 6,02 g/l, 4,63 g/l, 0,30 g/l,
Slovenian: Volulyte 6% 60 g/l, 6,02 g/l, 4,63 g/l,
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,42 , Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, sodium acetate trihydrate, malic acid
Slovenian: D-34212 Melsungen poli(0-2-hidroksietil)škrob 130 kDa mol.substitucija natrijev klorid kalijev klorid, kalcijev klorid dihidrat, magnezijev klorid heksahidrat, natrijev acetat trihidrat, jabolčna kislina
English: HES, Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate
Slovenian: HES, natrijev klorid, kalijev klorid, kalcijev klorid dihidrat, magnezijev klorid heksahidrat, natrijev acetat trihidrat
English: Vitafusal 10 % 100g/l, 6 g/l, 0.4 g/l, 0.134 g/l, 0.2 g/l, 3.7 g/l
Slovenian: Vitafusal 10 % 100g/l, 6 g/l, 0.4 g/l, 0.134 g/l, 0.2 g/l,
English: Vitakoll 10 % 100 g/l, 6 g/l, 0.4 g/l, 0.134 g/l, 0.2 g/l, 3.7 g/l
Slovenian: Vitakoll 10 % 100 g/l, 6 g/l, 0.4 g/l, 0.134 g/l, 0.2 g/l,
English: Poly(0-2hydroxyethyl)starch 200 kDa mol.substitution 0,45-0,55, Sodium chloride
Slovenian: D-34212 Melsungen poli(0-2-hidroksietil)škrob 200 kDa mol.substitucija natrijev klorid
English: Volulyte 6% 60 g/l, 4,63 g/l, 6,02 g/l, 0,3 g/l
Slovenian: Volulyte 6% 60 g/l, 4,63 g/l, 6,02 g/l,
English: Hydroxyethyl starch, Sodium acetate trihydrate, Sodium chloride, Sodium chloride, Magnesium chloride
Slovenian: hidroksietilškrob, natrijev acetat trihidrat, natrijev klorid, magnezijev klorid